Skip to main content
Erschienen in: Annals of Surgical Oncology 3/2010

01.10.2010 | American Society of Breast Surgeons

Use of Preoperative Magnetic Resonance Imaging for Invasive Lobular Cancer: Good, Better, but Maybe not the Best?

verfasst von: Lee J. McGhan, MB. BCh, Nabil Wasif, MD, Richard J. Gray, MD, Marina E. Giurescu, MD, Victor J. Pizzitola, MD, Roxanne Lorans, MD, Idris T. Ocal, MD, Chee-Chee H. Stucky, MD, Barbara A. Pockaj, MD

Erschienen in: Annals of Surgical Oncology | Sonderheft 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Invasive lobular cancer (ILC) of the breast is difficult to diagnose clinically and radiologically. It is hoped that preoperative magnetic resonance imaging (MRI) can improve evaluation of extent of disease.

Methods

Patients diagnosed with ILC at a single institution from 2001 to 2008 who underwent clinical breast examination (CBE), mammography, ultrasound, and MRI were studied retrospectively. Concordance between tumor size on imaging/CBE and pathologic size was defined as size within ±0.5 cm. Pearson correlation coefficients (R) were calculated for each modality. Local recurrence and reexcision rates were compared with those patients with ILC who did not undergo preoperative MRI.

Results

Seventy patients with ILC had all imaging modalities, including CBE, performed preoperatively. The sensitivity for detection of ILC by MRI was 99%. MRI-based tumor size was concordant with pathologic tumor size in 56% of tumors. MRI overestimated tumor size by >0.5 cm in 31% of tumors. Correlation of tumor size on imaging with final pathology was better for MRI (R = 0.75) than for mammography (R = 0.65), CBE (R = 0.63), or ultrasound (R = 0.45, all P < 0.01). Preoperative MRI was associated with lower reoperation rates for close/positive margins (P > 0.05).

Conclusions

For ILC, MRI has better sensitivity of detection and correlation with tumor size at pathology than CBE, mammography, or ultrasound. However, 31% of cases are overestimated by MRI, and correlation remains only at 0.75. The select use of MRI for preoperative estimation of tumor size in ILC is supported by our data, but the need for improvement and refinement of imaging remains.
Literatur
1.
Zurück zum Zitat Li CI, Anderson BO, Daling JR, Moe RE. Trends in incidence rates of invasive lobular carcinoma and ductal carcinoma of the breast. JAMA. 2003;289:1421–4.CrossRefPubMed Li CI, Anderson BO, Daling JR, Moe RE. Trends in incidence rates of invasive lobular carcinoma and ductal carcinoma of the breast. JAMA. 2003;289:1421–4.CrossRefPubMed
2.
Zurück zum Zitat Hanagiri T, Nozoe T, Mizukami M, et al. Clinicopathological characteristics if invasive lobular carcinoma of the breast. Asian J Surg. 2009;32:76–80.CrossRefPubMed Hanagiri T, Nozoe T, Mizukami M, et al. Clinicopathological characteristics if invasive lobular carcinoma of the breast. Asian J Surg. 2009;32:76–80.CrossRefPubMed
3.
Zurück zum Zitat Singletary SE, Patel-Parekh L, Bland KI. Treatment trends in early-stage invasive lobular carcinoma: a report from the National Cancer Data Base. Ann Surg. 2005;242:281–9.CrossRefPubMed Singletary SE, Patel-Parekh L, Bland KI. Treatment trends in early-stage invasive lobular carcinoma: a report from the National Cancer Data Base. Ann Surg. 2005;242:281–9.CrossRefPubMed
4.
Zurück zum Zitat Chung MA, Cole B, Wanebo HJ, et al. Optimal surgical treatment of invasive lobular carcinoma of the breast. Ann Surg Oncol. 1997;4:545–50.CrossRefPubMed Chung MA, Cole B, Wanebo HJ, et al. Optimal surgical treatment of invasive lobular carcinoma of the breast. Ann Surg Oncol. 1997;4:545–50.CrossRefPubMed
5.
Zurück zum Zitat Morrow M, Keeney K, Scholtens D, et al. Selecting patients for breast-conserving therapy: the importance of lobular histology. Cancer. 2006;106:2563–8.CrossRefPubMed Morrow M, Keeney K, Scholtens D, et al. Selecting patients for breast-conserving therapy: the importance of lobular histology. Cancer. 2006;106:2563–8.CrossRefPubMed
6.
Zurück zum Zitat Brem RF, Ioffe M, Rapelyea JA, et al. Invasive lobular carcinoma: detection with mammography, sonography, MRI, and breast-specific gamma imaging. AJR Am J Roentgenol. 2009;192:379–83.CrossRefPubMed Brem RF, Ioffe M, Rapelyea JA, et al. Invasive lobular carcinoma: detection with mammography, sonography, MRI, and breast-specific gamma imaging. AJR Am J Roentgenol. 2009;192:379–83.CrossRefPubMed
7.
Zurück zum Zitat Tse GMK, Chaiwun B, Wong K, et al. Magnetic resonance imaging of breast lesions—a pathologic correlation. Breast Cancer Res Treat. 2007;103:1–10.CrossRefPubMed Tse GMK, Chaiwun B, Wong K, et al. Magnetic resonance imaging of breast lesions—a pathologic correlation. Breast Cancer Res Treat. 2007;103:1–10.CrossRefPubMed
8.
Zurück zum Zitat Zakhireh J, Gomez R, Esserman L. Converting evidence to practice: a guide for the clinical application of MRI for the screening and management of breast cancer. Eur J Cancer. 2008;44:2742–52.CrossRefPubMed Zakhireh J, Gomez R, Esserman L. Converting evidence to practice: a guide for the clinical application of MRI for the screening and management of breast cancer. Eur J Cancer. 2008;44:2742–52.CrossRefPubMed
9.
Zurück zum Zitat Mann RM, Hoogeveen YL, Blickman JG, Boetes C. MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature. Breast Cancer Res Treat. 2008;107:1–14.CrossRefPubMed Mann RM, Hoogeveen YL, Blickman JG, Boetes C. MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature. Breast Cancer Res Treat. 2008;107:1–14.CrossRefPubMed
10.
Zurück zum Zitat Le Gal M, Ollivier L, Asselain B, et al. Mammographic features of 455 invasive lobular carcinomas. Radiology. 1992;185:705–8.PubMed Le Gal M, Ollivier L, Asselain B, et al. Mammographic features of 455 invasive lobular carcinomas. Radiology. 1992;185:705–8.PubMed
11.
Zurück zum Zitat Helvie MA, Paramagul C, Oberman HA, Adler DD. Invasive lobular carcinoma. Imaging features and clinical detection. Invest Radiol. 1993;28:202–7.CrossRefPubMed Helvie MA, Paramagul C, Oberman HA, Adler DD. Invasive lobular carcinoma. Imaging features and clinical detection. Invest Radiol. 1993;28:202–7.CrossRefPubMed
12.
Zurück zum Zitat Hilleren DJ, Anderson IT, Lindholm K, Linnell FS. Invasive lobular carcinoma: mammographic findings in a 10-year experience. Radiology. 1991;178:149–54.PubMed Hilleren DJ, Anderson IT, Lindholm K, Linnell FS. Invasive lobular carcinoma: mammographic findings in a 10-year experience. Radiology. 1991;178:149–54.PubMed
13.
Zurück zum Zitat Krecke KN, Gisvold JJ. Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients. AJR Am J Roentgenol. 1993;161:957–60.PubMed Krecke KN, Gisvold JJ. Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients. AJR Am J Roentgenol. 1993;161:957–60.PubMed
14.
Zurück zum Zitat Newstead GM, Baute PB, Toth HK. Invasive lobular and ductal carcinoma: mammographic findings and stage at diagnosis. Radiology. 1992;184:623–7.PubMed Newstead GM, Baute PB, Toth HK. Invasive lobular and ductal carcinoma: mammographic findings and stage at diagnosis. Radiology. 1992;184:623–7.PubMed
15.
Zurück zum Zitat Cornford EJ, Wilson AR, Athanassiou E, et al. Mammographic features of invasive lobular and invasive ductal carcinoma of the breast: a comparative analysis. Br J Radiol. 1995;68:450–3.CrossRefPubMed Cornford EJ, Wilson AR, Athanassiou E, et al. Mammographic features of invasive lobular and invasive ductal carcinoma of the breast: a comparative analysis. Br J Radiol. 1995;68:450–3.CrossRefPubMed
16.
Zurück zum Zitat Uchiyama N, Miyakawa K, Moriyama N, Kumazaki T. Radiographic features of invasive lobular carcinoma of the breast. Radiat Med. 2001;19:19–25.PubMed Uchiyama N, Miyakawa K, Moriyama N, Kumazaki T. Radiographic features of invasive lobular carcinoma of the breast. Radiat Med. 2001;19:19–25.PubMed
17.
Zurück zum Zitat Paramagul CP, Helvie MA, Adler DD. Invasive lobular carcinoma: sonographic appearance and role of sonography in improving diagnostic sensitivity. Radiology. 1995;195:231–4.PubMed Paramagul CP, Helvie MA, Adler DD. Invasive lobular carcinoma: sonographic appearance and role of sonography in improving diagnostic sensitivity. Radiology. 1995;195:231–4.PubMed
18.
Zurück zum Zitat Cawson JN, Law EM, Kavanagh AM. Invasive lobular carcinoma: sonographic features of cancers detected in a BreastScreen Program. Australas Radiol. 2001;45:25–30.CrossRefPubMed Cawson JN, Law EM, Kavanagh AM. Invasive lobular carcinoma: sonographic features of cancers detected in a BreastScreen Program. Australas Radiol. 2001;45:25–30.CrossRefPubMed
19.
Zurück zum Zitat Selinko VL, Middleton LP, Dempsey PJ. Role of sonography in diagnosing and staging invasive lobular carcinoma. J Clin Ultrasound. 2004;32:323–32.CrossRefPubMed Selinko VL, Middleton LP, Dempsey PJ. Role of sonography in diagnosing and staging invasive lobular carcinoma. J Clin Ultrasound. 2004;32:323–32.CrossRefPubMed
20.
Zurück zum Zitat Chapellier C, Balu-Maestro C, Bleuse A, Ettore F, Bruneton JN. Ultrasonography of invasive lobular carcinoma of the breast: sonographic patterns and diagnostic value: report of 102 cases. Clin Imaging. 2000;24:333–6.CrossRefPubMed Chapellier C, Balu-Maestro C, Bleuse A, Ettore F, Bruneton JN. Ultrasonography of invasive lobular carcinoma of the breast: sonographic patterns and diagnostic value: report of 102 cases. Clin Imaging. 2000;24:333–6.CrossRefPubMed
21.
Zurück zum Zitat Rissanen T, Tikkakoski T, Autio AL, Apaja-Sarkkinen M. Ultrasonography of invasive lobular breast carcinoma. Acta Radiol. 1998;39:285–91.PubMed Rissanen T, Tikkakoski T, Autio AL, Apaja-Sarkkinen M. Ultrasonography of invasive lobular breast carcinoma. Acta Radiol. 1998;39:285–91.PubMed
22.
Zurück zum Zitat Evans N, Lyons K. The use of ultrasound in the diagnosis of invasive lobular carcinoma of the breast less than 10 mm in size. Clin Radiol. 2000;24:333–6. Evans N, Lyons K. The use of ultrasound in the diagnosis of invasive lobular carcinoma of the breast less than 10 mm in size. Clin Radiol. 2000;24:333–6.
23.
Zurück zum Zitat Skaane P, Skjorten F. Ultrasonographic evaluation of invasive lobular carcinoma. Acta Radiol. 1999;40:369–75.CrossRefPubMed Skaane P, Skjorten F. Ultrasonographic evaluation of invasive lobular carcinoma. Acta Radiol. 1999;40:369–75.CrossRefPubMed
24.
Zurück zum Zitat Liberman L, Morris EA, Dershaw DD, Abramson AF, Tan LK. Ductal enhancement on MR imaging of the breast. AJR Am J Roentgenol. 2003;181:519–25.PubMed Liberman L, Morris EA, Dershaw DD, Abramson AF, Tan LK. Ductal enhancement on MR imaging of the breast. AJR Am J Roentgenol. 2003;181:519–25.PubMed
25.
Zurück zum Zitat Kepple J, Layeeque R, Klimberg S, et al. Correlation of magnetic resonance imaging and pathologic size of infiltrating lobular carcinoma of the breast. Am J Surg. 2005;190:623–7.CrossRefPubMed Kepple J, Layeeque R, Klimberg S, et al. Correlation of magnetic resonance imaging and pathologic size of infiltrating lobular carcinoma of the breast. Am J Surg. 2005;190:623–7.CrossRefPubMed
26.
Zurück zum Zitat Lopez JK, Bassett LW. Invasive lobular carcinoma of the breast: spectrum of mammographic, US and MR imaging findings. Radiographics. 2009;29:165–76.CrossRefPubMed Lopez JK, Bassett LW. Invasive lobular carcinoma of the breast: spectrum of mammographic, US and MR imaging findings. Radiographics. 2009;29:165–76.CrossRefPubMed
27.
Zurück zum Zitat Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology. 2001;220:13–30.PubMed Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology. 2001;220:13–30.PubMed
28.
Zurück zum Zitat Fabre Demard N, Boulet P, Prat X, et al. Breast MRI in invasive lobular carcinoma: diagnosis and staging. J Radiol. 2005;86:1027–34.CrossRefPubMed Fabre Demard N, Boulet P, Prat X, et al. Breast MRI in invasive lobular carcinoma: diagnosis and staging. J Radiol. 2005;86:1027–34.CrossRefPubMed
29.
Zurück zum Zitat Qayyum A, Birdwell RL, Daniel BL, et al. MR imaging features of infiltrating lobular carcinoma of the breast: histopathologic correlation. AJR Am J Roentgenol. 2002;178:1227–32.PubMed Qayyum A, Birdwell RL, Daniel BL, et al. MR imaging features of infiltrating lobular carcinoma of the breast: histopathologic correlation. AJR Am J Roentgenol. 2002;178:1227–32.PubMed
30.
Zurück zum Zitat Rodenko GN, Harms SE, Pruneda JM, et al. MR imaging in the management before surgery of lobular carcinoma of the breast: correlation with pathology. AJR Am J Roentgenol. 1996;167:1415–9.PubMed Rodenko GN, Harms SE, Pruneda JM, et al. MR imaging in the management before surgery of lobular carcinoma of the breast: correlation with pathology. AJR Am J Roentgenol. 1996;167:1415–9.PubMed
31.
Zurück zum Zitat Schelfout K, Van GM, Kersschot E, et al. Preoperative breast MRI in patients with invasive lobular breast cancer. Eur Radiol. 2004;14:1209–16.CrossRefPubMed Schelfout K, Van GM, Kersschot E, et al. Preoperative breast MRI in patients with invasive lobular breast cancer. Eur Radiol. 2004;14:1209–16.CrossRefPubMed
32.
Zurück zum Zitat Yeh ED, Slanetz PJ, Edmister WB, et al. Invasive lobular carcinoma: spectrum of enhancement and morphology on magnetic resonance imaging. Breast J. 2003;9:13–8.CrossRefPubMed Yeh ED, Slanetz PJ, Edmister WB, et al. Invasive lobular carcinoma: spectrum of enhancement and morphology on magnetic resonance imaging. Breast J. 2003;9:13–8.CrossRefPubMed
33.
Zurück zum Zitat Foote FWJ, Stewart FW. Histologic classification of carcinoma of the breast. Surgery. 1946;19:74–99. Foote FWJ, Stewart FW. Histologic classification of carcinoma of the breast. Surgery. 1946;19:74–99.
34.
Zurück zum Zitat Dixon JM, Anderson TJ, Page DL, Lee D, Duffy SW. Infiltrating lobular carcinoma of the breast. Histopathology. 1982;6:149–61.CrossRefPubMed Dixon JM, Anderson TJ, Page DL, Lee D, Duffy SW. Infiltrating lobular carcinoma of the breast. Histopathology. 1982;6:149–61.CrossRefPubMed
35.
Zurück zum Zitat Grimsby GM, Gray R, Dueck A, et al. Is there concordance of invasive breast cancer pathologic tumor size with magnetic resonance imaging? Am J Surg. 2009;198:500–4.CrossRefPubMed Grimsby GM, Gray R, Dueck A, et al. Is there concordance of invasive breast cancer pathologic tumor size with magnetic resonance imaging? Am J Surg. 2009;198:500–4.CrossRefPubMed
36.
Zurück zum Zitat Onesti JK, Mangus BE, Helmer SD, Osland JS. Breast cancer tumor size: correlation between magnetic resonance imaging and pathology measurements. Am J Surg. 2008;196:844–50.CrossRefPubMed Onesti JK, Mangus BE, Helmer SD, Osland JS. Breast cancer tumor size: correlation between magnetic resonance imaging and pathology measurements. Am J Surg. 2008;196:844–50.CrossRefPubMed
37.
Zurück zum Zitat Mann RM, Veltman J, Barentsz JO, et al. The value of MRI compared to mammography in the assessment of tumor extent in invasive lobular carcinoma of the breast. Eur J Surg Oncol. 2008;34:135–42.PubMed Mann RM, Veltman J, Barentsz JO, et al. The value of MRI compared to mammography in the assessment of tumor extent in invasive lobular carcinoma of the breast. Eur J Surg Oncol. 2008;34:135–42.PubMed
38.
Zurück zum Zitat Caramella T, Chapellier C, Ettore F, et al. Value of MRI in the surgical planning of invasive lobular carcinoma: a prospective and a retrospective study of 57 cases, comparison with physical examination, conventional imaging, and histology. Clin Imaging. 2007;31:155–61.CrossRefPubMed Caramella T, Chapellier C, Ettore F, et al. Value of MRI in the surgical planning of invasive lobular carcinoma: a prospective and a retrospective study of 57 cases, comparison with physical examination, conventional imaging, and histology. Clin Imaging. 2007;31:155–61.CrossRefPubMed
39.
Zurück zum Zitat Boetes C, Veltman J, van Die L, et al. The role of MRI in invasive lobular carcinoma. Breast Cancer Res Treat. 2004;86:31–7.CrossRefPubMed Boetes C, Veltman J, van Die L, et al. The role of MRI in invasive lobular carcinoma. Breast Cancer Res Treat. 2004;86:31–7.CrossRefPubMed
40.
Zurück zum Zitat Wasif N, Garreau J, Terando A, et al. MRI versus ultrasonography and mammography for preoperative assessment of breast cancer. Am Surg. 2009;75:970–5.PubMed Wasif N, Garreau J, Terando A, et al. MRI versus ultrasonography and mammography for preoperative assessment of breast cancer. Am Surg. 2009;75:970–5.PubMed
41.
Zurück zum Zitat Morrow M. Magnetic resonance imaging in breast cancer: one step forward, two steps back? JAMA. 2004;292:2779–80.CrossRefPubMed Morrow M. Magnetic resonance imaging in breast cancer: one step forward, two steps back? JAMA. 2004;292:2779–80.CrossRefPubMed
42.
Zurück zum Zitat Berg WA, Guitierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US and MR imaging in the preoperative assessment of breast cancer. Radiology. 2004;233:830–49.CrossRefPubMed Berg WA, Guitierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US and MR imaging in the preoperative assessment of breast cancer. Radiology. 2004;233:830–49.CrossRefPubMed
43.
Zurück zum Zitat Mann RM, Loo CE, Wobbes T, et al. The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast. Breast Cancer Res Treat. 2010;119:415–22.CrossRefPubMed Mann RM, Loo CE, Wobbes T, et al. The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast. Breast Cancer Res Treat. 2010;119:415–22.CrossRefPubMed
44.
Zurück zum Zitat Lehman CD, Gatsonis C, Kuhl CK, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007;356:1295–303.CrossRefPubMed Lehman CD, Gatsonis C, Kuhl CK, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007;356:1295–303.CrossRefPubMed
45.
Zurück zum Zitat Carpenter SG, Stucky CC, Dueck AC, et al. Scientific Presentation Award: the impact of magnetic resonance imaging on surgical treatment of invasive breast cancer. Am J Surg. 2009;198:475–81.CrossRefPubMed Carpenter SG, Stucky CC, Dueck AC, et al. Scientific Presentation Award: the impact of magnetic resonance imaging on surgical treatment of invasive breast cancer. Am J Surg. 2009;198:475–81.CrossRefPubMed
Metadaten
Titel
Use of Preoperative Magnetic Resonance Imaging for Invasive Lobular Cancer: Good, Better, but Maybe not the Best?
verfasst von
Lee J. McGhan, MB. BCh
Nabil Wasif, MD
Richard J. Gray, MD
Marina E. Giurescu, MD
Victor J. Pizzitola, MD
Roxanne Lorans, MD
Idris T. Ocal, MD
Chee-Chee H. Stucky, MD
Barbara A. Pockaj, MD
Publikationsdatum
01.10.2010
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe Sonderheft 3/2010
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-1266-y

Weitere Artikel der Sonderheft 3/2010

Annals of Surgical Oncology 3/2010 Zur Ausgabe

American Society of Breast Surgeons

Controversies in Breast Surgery

American Society of Breast Surgeons

Pure Tubular Carcinoma and Axillary Nodal Metastases

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.